Dow Jones

40 211,72

0,00%

DAX

Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.

S'inscrire

INSM

Insmed (INSM)

Insmed Inc

De:

Actualités Réglementées

Mots clefs:

Trier par:

Actualités Non-réglementées

Showing the most relevant articles for your search:NASDAQ:INSM

<< Précédent 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 Suivant >>

Date	Heure	Source	Titre	Symbole	Société
24/05/2013	22h16	Edgar (US Regulatory)	Securities Registration Statement (simplified Form) (s-3)	NASDAQ:INSM	Insmed Inc
14/05/2013	14h00	Marketwired	Insmed Granted Key Composition of Matter Patent Allowance for ARIKACE in Europe	NASDAQ:INSM	Insmed Inc
13/05/2013	14h00	Marketwired	Insmed to Present at the UBS Global Healthcare Conference	NASDAQ:INSM	Insmed Inc
10/05/2013	18h52	Marketwired	Insmed to Present at the Bank of America Merrill Lynch 2013 Health Care Conference	NASDAQ:INSM	Insmed Inc
08/05/2013	16h50	Edgar (US Regulatory)	Confidential Treatment Order (ct Order)	NASDAQ:INSM	Insmed Inc
07/05/2013	13h35	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:INSM	Insmed Inc
07/05/2013	13h32	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:INSM	Insmed Inc
07/05/2013	13h30	Marketwired	Insmed Reports First Quarter Financial Results	NASDAQ:INSM	Insmed Inc
01/05/2013	14h00	Marketwired	Insmed to Host First Quarter 2013 Financial Results Conference Call on Tuesday, May 7, 2013	NASDAQ:INSM	Insmed Inc
18/04/2013	23h02	Edgar (US Regulatory)	Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)	NASDAQ:INSM	Insmed Inc
18/04/2013	14h00	Marketwired	Insmed to Present at the 12th Annual Needham Healthcare Conference	NASDAQ:INSM	Insmed Inc
04/04/2013	18h15	Zacks	Orphan Status for Insmed's Arikace - Analyst Blog	NASDAQ:INSM	Insmed Inc
03/04/2013	22h34	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:INSM	Insmed Inc
03/04/2013	22h31	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	NASDAQ:INSM	Insmed Inc
01/04/2013	22h33	Marketwired	Insmed Appoints Matthew Pauls as Chief Commercial Officer	NASDAQ:INSM	Insmed Inc
28/03/2013	13h00	Marketwired	ARIKACE Receives Orphan Drug Designation for Treating Infections Caused by Non-Tuberculous Mycobacteria	NASDAQ:INSM	Insmed Inc
27/03/2013	13h00	Marketwired	Insmed to Present at Future Leaders in the Biotech Industry Conference	NASDAQ:INSM	Insmed Inc
18/03/2013	12h41	Marketwired	Insmed Reports Fourth Quarter and Full Year 2012 Financial Results	NASDAQ:INSM	Insmed Inc
18/03/2013	12h31	Edgar (US Regulatory)	Annual Report (10-k)	NASDAQ:INSM	Insmed Inc
11/03/2013	14h54	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:INSM	Insmed Inc
11/03/2013	13h00	Marketwired	Insmed to Host Fourth Quarter and Full Year 2012 Financial Results Conference Call on Monday, March 18, 2013	NASDAQ:INSM	Insmed Inc
26/02/2013	14h00	Marketwired	Insmed to Present at Two Upcoming Investor Conferences	NASDAQ:INSM	Insmed Inc
06/02/2013	14h00	Marketwired	Insmed to Present at Two Upcoming Healthcare Investor Conferences	NASDAQ:INSM	Insmed Inc
17/01/2013	20h06	PR Newswire (US)	The Law Firm of Levi & Korsinsky, LLP Launches an Investigation into Possible Breaches of Fiduciary Duty by the Board of Dire...	NASDAQ:INSM	Insmed Inc
15/01/2013	23h05	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:INSM	Insmed Inc
15/01/2013	23h02	Edgar (US Regulatory)	Post-effective Amendment (investment Company, Rule 485(b)) (485bpos)	NASDAQ:INSM	Insmed Inc
13/12/2012	14h00	PR Newswire (US)	Insmed to Present at 31st Annual J.P. Morgan Healthcare Conference	NASDAQ:INSM	Insmed Inc
07/12/2012	12h01	Edgar (US Regulatory)	Amended Statement of Ownership (SC 13G/A)	NASDAQ:INSM	Insmed Inc
03/12/2012	13h01	Edgar (US Regulatory)	Current report filing (8-K)	NASDAQ:INSM	Insmed Inc
13/11/2012	14h00	PR Newswire (US)	Insmed Announces CLEAR-108 Phase 3 Clinical Study of ARIKACE® in Cystic Fibrosis Patients with Pseudomonas Lung Infections H...	NASDAQ:INSM	Insmed Inc